Laura Wilkinson, FNP in Middlebury, VT - Medicare Nurse Practitioner

Laura Wilkinson, FNP is a medicare enrolled "Nurse Practitioner" in Middlebury, Vermont. She graduated from nursing school in 2005 and has 19 years of diverse experience with area of expertise as Nurse Practitioner. She is a member of the group practice Village Health, Inc. and her current practice location is 116 Porter Dr, Middlebury, Vermont. You can reach out to her office (for appointments etc.) via phone at (802) 388-8805.

Laura Wilkinson is licensed to practice in Vermont (license number 101-0060890) and she also participates in the medicare program. She accepts medicare assignments (which means she accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and her NPI Number is 1093720716.

Contact Information

	Laura Wilkinson, FNP
	116 Porter Dr, Middlebury, VT 05753-8501
	(802) 388-8805
	(802) 388-5619

Provider's Profile

Full Name	Laura Wilkinson
Gender	Female
Speciality	Nurse Practitioner
Experience	19 Years
Location	116 Porter Dr, Middlebury, Vermont
Accepts Medicare Assignments	Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.

Medical Education and Training:

Laura Wilkinson graduated from nursing school in 2005

NPI Data:

NPI Number: 1093720716
Provider Enumeration Date: 07/30/2006
Last Update Date: 11/03/2011

Medicare PECOS Information:

PECOS PAC ID: 5294816153
Enrollment ID: I20110201000649

Medical Identifiers

Medical identifiers for Laura Wilkinson such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1093720716	NPI	-	NPPES
1017866	Medicaid	VT
00630039	Medicaid	NY

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
363L00000X	Nurse Practitioner	334746 (New York)	Secondary
363L00000X	Nurse Practitioner	101-0060890 (Vermont)	Primary

Medical Facilities Affiliation

Facility Name	Location	Facility Type
Porter Hospital, Inc	Middlebury, VT	Hospital

Group Practice Association

Group Practice Name	Group PECOS PAC ID	No. of Members
Village Health, Inc.	8224463229	2

News Archive

Clinical trial shows reduction in mortality for children with severe Langerhans cell histiocytosis

A new international study finds that introducing an increased intensity of chemotherapy in children with severe Langerhans cell histiocytosis (LCH) can reduce the mortality rate for this disorder by as much as 20 percent when the patient demonstrates a rapid response to such treatment.

New GE SPHHS building to serve as convening place for public health leaders

The George Washington University announced today plans to begin construction of a new building for its School of Public Health and Health Services on Pennsylvania Avenue, to be completed in the summer of 2014.

Sargramostim drug can also improve memory in people with mild-to-moderate Alzheimer's disease

A new study suggests that Sargramostim, a medication often used to boost white blood cells after cancer treatments, is also effective in treating and improving memory in people with mild-to-moderate Alzheimer's disease.

Neurons derived from precursor cells may regulate innate reproductive and aggressive behaviors

Neurons derived from two different types of precursor cells that later develop into neurons in the medial amygdala - one of the interconnected structures in the brain involved in emotion, motivation and memory - help to program innate reproductive and aggressive behaviors into the brain, research led by Children's National Health System indicates.

Health Canada approves Lucentis (ranibizumab) for myopic CNV

Novartis Pharmaceuticals Canada Inc. announced today that Lucentis (ranibizumab), the treatment for several major causes of vision loss, has been approved by Health Canada for the treatment of visual impairment due to choroidal neovascularization (CNV) secondary to pathologic myopia (myopic CNV).

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Laura Wilkinson allows following entities to bill medicare on her behalf.

Entity Name	Village Health, Inc.
Entity Type	Part B Supplier - Clinic/group Practice
Entity Identifiers	NPI Number: 1992353445 PECOS PAC ID: 8224463229 Enrollment ID: O20200122000850

News Archive

Clinical trial shows reduction in mortality for children with severe Langerhans cell histiocytosis

New GE SPHHS building to serve as convening place for public health leaders

Sargramostim drug can also improve memory in people with mild-to-moderate Alzheimer's disease

Neurons derived from precursor cells may regulate innate reproductive and aggressive behaviors

Health Canada approves Lucentis (ranibizumab) for myopic CNV

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Laura Wilkinson is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Laura Wilkinson, FNP 116 Porter Dr, Po Box 357, Middlebury, VT 05753-8501 Ph: (802) 388-8805	Laura Wilkinson, FNP 116 Porter Dr, Middlebury, VT 05753-8501 Ph: (802) 388-8805

News Archive

Clinical trial shows reduction in mortality for children with severe Langerhans cell histiocytosis

New GE SPHHS building to serve as convening place for public health leaders

Sargramostim drug can also improve memory in people with mild-to-moderate Alzheimer's disease

Neurons derived from precursor cells may regulate innate reproductive and aggressive behaviors

Health Canada approves Lucentis (ranibizumab) for myopic CNV

Nurse Practitioner Nurses in Middlebury, VT

Rachel A Guy, NP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 102 Court St, Middlebury, VT 05753 Phone: 802-388-2765
Mary Gill, NP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 110 Porter Drive, Middlebury, VT 05753 Phone: 802-388-7959 Fax: 802-388-8136
Stacy Ann Macfarlane, APRN Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 115 Porter Dr, Middlebury, VT 05753 Phone: 802-388-4701
Leslie Gerdinier Orelup, FNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 44 Collins Dr, Suite 201, Middlebury, VT 05753 Phone: 802-388-1500 Fax: 802-388-0441
Kathleen Lombard, FNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 44 Collins Dr Ste 202, Middlebury, VT 05753 Phone: 802-388-1338 Fax: 802-388-8244
Louisa Veazie Pratt, NP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 115 Porter Dr, Middlebury, VT 05753 Phone: 802-388-4701

Laura Wilkinson, FNP - Medicare Nurse Practitioner in Middlebury, VT

Contact Information

Provider's Profile

Medical Identifiers

Medical Taxonomies and Licenses

Medical Facilities Affiliation

Group Practice Association

Clinical trial shows reduction in mortality for children with severe Langerhans cell histiocytosis

New GE SPHHS building to serve as convening place for public health leaders

Sargramostim drug can also improve memory in people with mild-to-moderate Alzheimer's disease

Neurons derived from precursor cells may regulate innate reproductive and aggressive behaviors

Health Canada approves Lucentis (ranibizumab) for myopic CNV

Medicare Reassignments

Clinical trial shows reduction in mortality for children with severe Langerhans cell histiocytosis

New GE SPHHS building to serve as convening place for public health leaders

Sargramostim drug can also improve memory in people with mild-to-moderate Alzheimer's disease

Neurons derived from precursor cells may regulate innate reproductive and aggressive behaviors

Health Canada approves Lucentis (ranibizumab) for myopic CNV

Medicare Part D Prescriber Enrollment

Mailing Address and Practice Location

Clinical trial shows reduction in mortality for children with severe Langerhans cell histiocytosis

New GE SPHHS building to serve as convening place for public health leaders

Sargramostim drug can also improve memory in people with mild-to-moderate Alzheimer's disease

Neurons derived from precursor cells may regulate innate reproductive and aggressive behaviors

Health Canada approves Lucentis (ranibizumab) for myopic CNV

Nurse Practitioner Nurses in Middlebury, VT